Viewpoints on Innovation

Chronic Problem #4: Rampant Incrementalism

Governance Organizational Effectiveness Consumer Goods High Technology Industrial Manufacturing Medical Device Pharmaceutical Chief Innovation Officer

New product portfolios are overwhelmed with small, incremental, low-risk initiatives that have commensurately small, short-term, low risk payoffs. These range from minor product, packaging and labeling tweaks that do not affect the substance of the product, to small line extensions and product improvements that are not likely to move the needle on sales, margins, or market share.

Research published last fall by Stage-Gate, Inc. shows an 80% increase in the number of projects that fall into the incremental category in just the last ten years. At the same time, projects producing new to the world innovations have dropped by over 40%. The financial crisis certainly had an impact on the risk companies were willing to take, but six years beyond the worst of that contraction, the problem still persists.

One of the culprits is the increase in the indiscriminant use of financial models that treat all investment alternatives the same. Breakthrough innovation initiatives should be evaluated using financial tools, but the level of uncertainty inherent in new to the world concepts forces us to apply more management judgment to the decision than a model that is forcing a decision between multiple sure things.

The real problem here is that a low-risk, incremental portfolio actually represents a giant risk to the long-term viability of the organization. Companies that do not invest in real innovation will eventually be replaced by those that do, or disrupted by an upstart with an inferior product that has broader market appeal. Low risk does not always mean safe.

Originally published on 

More In This Series

Seven Chronic Problems

Chronic Problem #1: Lack of a Strategy

Chronic Problem #2: Lack of Alignment

Chronic Problem #3: Overloaded Pipeline

Chronic Problem #4: Rampant Incrementalism

Chronic Problem #5: Unclear Accountability

Chronic Problem #6: Short-term Orientation

Chronic Problem #7: Lack of Skills

Originally published on July 3rd, 2014

What's your view? Add your question or comment

Topics: Bill Poston, Chief Innovation Officer, Incremental Innovation, Innovation, Innovation Types, Low Risk, Pipeline Productivity, Portfolio Pipeline Management

About the Author

Bill Poston

Bill Poston

For the past 30 years, Bill has helped executives in technology-driven industries transform their competencies to deliver results. He is a highly regarded consultant, speaker, and writer on the topics of innovation strategy, product development, portfolio management, technology commercialization, and the software systems that enable innovation. Keep up with Bill's latest research and thoughts on innovation and the rising role of the Chief Innovation Officer at
More Viewpoints by Bill Poston

What's Your View?

comments powered by Disqus

Don't miss future posts.
Get Viewpoints Digests delivered right to your inbox.

Subscribe Now Leave me alone